These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34901221)
21. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation. Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244 [TBL] [Abstract][Full Text] [Related]
22. Antithrombotic therapy after acute ischemic stroke in patients with atrial fibrillation. McGrath ER; Kapral MK; Fang J; Eikelboom JW; Conghaile Aó; Canavan M; O'Donnell MJ; Stroke; 2014 Dec; 45(12):3637-42. PubMed ID: 25378422 [TBL] [Abstract][Full Text] [Related]
23. Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study. Park J; Choi EK; Han KD; Choi YJ; Lee SR; Cha MJ; Kang J; Park KW; Oh S; Lip GYH Am J Cardiol; 2019 Jun; 123(12):1921-1926. PubMed ID: 30967291 [TBL] [Abstract][Full Text] [Related]
24. Missed Opportunities to Initiate Oral Anticoagulant in Atrial Fibrillation: Insights from Australian Acute Coronary Syndrome Registries. Ma M; Hyun K; D'Souza M; Chew D; Brieger D Heart Lung Circ; 2021 Aug; 30(8):1157-1165. PubMed ID: 33642171 [TBL] [Abstract][Full Text] [Related]
25. Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation. Bernard A; Fauchier L; Pellegrin C; Clementy N; Saint Etienne C; Banerjee A; Naudin D; Angoulvant D Thromb Haemost; 2013 Sep; 110(3):560-8. PubMed ID: 23846210 [TBL] [Abstract][Full Text] [Related]
26. Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry. Hsu JC; Maddox TM; Kennedy KF; Katz DF; Marzec LN; Lubitz SA; Gehi AK; Turakhia MP; Marcus GM JAMA Cardiol; 2016 Apr; 1(1):55-62. PubMed ID: 27437655 [TBL] [Abstract][Full Text] [Related]
27. A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Sullivan AE; Nanna MG; Rao SV; Cantrell S; Gibson CM; Verheugt FWA; Peterson ED; Lopes RD; Alexander JH; Granger CB; Yee MK; Kong DF Catheter Cardiovasc Interv; 2020 Aug; 96(2):E102-E109. PubMed ID: 31713326 [TBL] [Abstract][Full Text] [Related]
28. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry. Dai Y; Yang J; Gao Z; Xu H; Sun Y; Wu Y; Gao X; Li W; Wang Y; Gao R; Yang Y; BMC Cardiovasc Disord; 2017 Jan; 17(1):2. PubMed ID: 28052755 [TBL] [Abstract][Full Text] [Related]
29. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents. Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773 [TBL] [Abstract][Full Text] [Related]
30. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention. Saito Y; Kobayashi Y J Cardiol; 2019 Jan; 73(1):1-6. PubMed ID: 30293674 [TBL] [Abstract][Full Text] [Related]
31. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN. Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282 [TBL] [Abstract][Full Text] [Related]
32. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881 [TBL] [Abstract][Full Text] [Related]
33. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. Shantsila E; Wolff A; Lip GY; Lane DA Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312 [TBL] [Abstract][Full Text] [Related]
34. CHA2DS2-VASc score in acute ischemic stroke with atrial fibrillation: results from the Clinical Research Collaboration for Stroke in Korea. Lee HL; Kim JT; Lee JS; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Oh MS; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Park MS; Choi KH; Cho KH; Lee J; Bae HJ Sci Rep; 2021 Jan; 11(1):793. PubMed ID: 33436977 [TBL] [Abstract][Full Text] [Related]
35. Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence? Ancedy Y; Lecoq C; Saint Etienne C; Ivanes F; Angoulvant D; Babuty D; Lip GY; Fauchier L Int J Cardiol; 2016 Jan; 203():987-94. PubMed ID: 26625327 [TBL] [Abstract][Full Text] [Related]
36. Real-world antithrombotic therapies and clinical outcomes after second-generation drug-eluting stent implantation in patients with atrial fibrillation: a multi-center cohort study. Otsuki H; Yamaguchi J; Kamishima K; Arashi H; Hagiwara N Heart Vessels; 2018 Sep; 33(9):986-996. PubMed ID: 29549436 [TBL] [Abstract][Full Text] [Related]
37. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018 [TBL] [Abstract][Full Text] [Related]
38. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events. Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG; Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742 [TBL] [Abstract][Full Text] [Related]
39. [Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation]. Darius H Dtsch Med Wochenschr; 2020 Jul; 145(14):978-986. PubMed ID: 32668469 [TBL] [Abstract][Full Text] [Related]
40. Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Goto K; Nakai K; Shizuta S; Morimoto T; Shiomi H; Natsuaki M; Yahata M; Ota C; Ono K; Makiyama T; Nakagawa Y; Furukawa Y; Kadota K; Takatsu Y; Tamura T; Takizawa A; Inada T; Doi O; Nohara R; Matsuda M; Takeda T; Kato M; Shirotani M; Eizawa H; Ishii K; Lee JD; Takahashi M; Horie M; Takahashi M; Miki S; Aoyama T; Suwa S; Hamasaki S; Ogawa H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T; Am J Cardiol; 2014 Jul; 114(1):70-8. PubMed ID: 24925801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]